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Abstract
PGE2 plays an important role in a broad spectrum of physiological and pathological pro-
cesses mediated through a membrane-bound G protein-coupled receptor (GPCR) called
EP receptor. In mammals, four subtypes of EP receptor (EP 1-4) are identified and each of
them functions through different signal transduction pathways. Orthologous EP receptors
have also been identified in other non-mammalian species, such as chicken and zebrafish.
EP4 is the only identified PGE2 receptor to date in Atlantic salmon but its tissue distribution
and function have not been studied in any detail. In this study, we first sequenced EP4 re-
ceptor in different tissues and found that the presence of the 3nt deletion in the 5’ untranslat-
ed region was accompanied by silent mutation at nt 668. While attempting to amplify the
same sequence in TO cells (an Atlantic salmon macrophage-like cell line), we failed to ob-
tain the full-length product. Further investigation revealed different isoform of EP4 receptor
in TO cells and we subsequently documented its presence in different Atlantic salmon tis-
sues. These two isoforms of EP4 receptor share high homology in their first half of se-
quence but differ in the second half part with several deletion segments though the final
length of coding sequence is the same for two isoforms. We further studied the immunomo-
dulation effect of PGE2 in TO cells and found that PGE2 inhibited the induction of CXCL-10,
CCL-4, IL-8 and IL-1β genes expression in a time dependent manner and without cAMP
upregulation.
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Introduction
Prostaglandins (PG) are arachidonic acid (AA) metabolites that serve several biological and
physiological functions. They are produced when AA is released from the plasma membrane by
phospholipases and metabolized by cyclooxygenases (also known as PG synthases) [1]. PGs are
ubiquitously produced in the body. They act in an autocrine or paracrine manner by activating
intracellular signaling cascade through rhodopsin-like 7 transmembrane-spanning G protein
coupled receptors [2]. Four different bioactive PGs are found; PGE2, prostacycline (PGI2), PGD2
and PGF2α. Among these different PGs, PGE2 has the broadest range of biological actions and is
known for its diverse role in inflammation, immune response and reproduction [3–6].
As for other PGs, PGE2 exerts its function by binding to its specific receptors leading to activa-
tion of intracellular signaling and gene transcription. Four different PGE2 receptors have been
identified designated as EP1, EP2, EP3 and EP4 receptors. While these receptors are highly con-
served between mammalian species, significant differences in the structure and pharmacology
exist between the different subtypes [7]. EP4 receptor is characterized by its long carboxyl termi-
nus which is important for agonist-induced desensitization [8]. EP3 receptors are distinguished
by the presence of multiple variants generated by alternative splicing of the C terminus [9].
Each of the EP receptors has distinct signal transduction properties and tissue and cellular distri-
bution. In mice, for example, EP3 and EP4 are the most widely distributed subtypes whereas EP2 is
the least abundant [10]. The signaling cascade induced by EP1 is coupled to phospholipase C/l-
1,4,5-trisphosphate signaling pathway, and leads to mobilization of intracellular calcium [11], while
signaling through EP2 and EP4 receptor results in increased intracellular cyclic AMP (cAMP) levels
via coupling to Gs proteins [12]. Signaling through EP3, on the other hand, is coupled to a Gi pro-
tein and results in reduction in intracellular cAMP levels [13]. However, activation of at least one
EP3 splice variant can also lead to increased cAMP levels, suggesting functional coupling to a Gs
protein [14]. This diversity in receptor and signal transduction property is largely responsible for
the pleiotropic effect of PGE2. For example, EP2 and EP4 can mediate both pro- and anti-inflam-
matory effects while the responses induced by EP1 and EP3 are mostly pro-inflammatory [15].
Presence of PGE2 in the aquatic invertebrates and vertebrates has been reported since the
1970s [16,17]. Since then, investigators have studied different aspects of PGE response in sever-
al fish species. In contrast, detailed information about receptor subtypes and their functions
are still lacking. The best-studied fish species with regard to EP4 receptors is zebrafish. Al-
though all the four subtypes are found [18–20], basic information such as the tissue distribu-
tion and the functions they play is still lacking. Presence of multiple isoforms for EP2 and EP4
suggests that functional differences may exist between these receptors and their mammalian
counterparts. Whether presence of multiple isoform for EP2 and EP4 is a common feature
across fish species or rather specific to the zebrafish is not known. For Atlantic salmon, the
only identified PGE2 receptor so far is EP4 [21]. In the present study we aimed to investigate
the presence and distribution of EP4 receptor in Atlantic salmon and evaluate its immunomo-
dulation effect in vitro using TO cells, a salmon macrophage-like cell line as a model. To our
surprise, a different EP4 isoform was identified in TO cells and this sequence was shown to be
present also in Atlantic salmon tissues. We further studied the immunomodulation inferred by
PGE2 and showed the effect likely through a cAMP-independent pathway.
Materials and Methods
Cell culture
Chinook salmon embryonic cells (CHSE-214) [22], TO cells, a macrophage-like cell line origi-
nating from Atlantic salmon head kidney leukocytes [23], and Rainbow trout gonad cells
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(RTG-2) [24] were maintained at 20°C in L-15 glutamax media (Invitrogen) supplemented
with 10% FBS (Invitrogen). During PGE2 stimulation experiment 50μg/mL gentamycin was
additionally added to the media.
RNA isolation and cDNA synthesis
Total RNA was isolated from TO cells, headkidney macrophages and different Atlantic salmon
tissues. For TO cells and macrophages, RNA was extracted using RNeasy Plus mini kit (Qia-
gen) following the manufacturer’s protocol while a combination of Trizol and RNeasy mini kit
procedures was used for the tissues. For the latter, approximately 30mg tissues were added to
eppendorf tubes containing 1ml ISol-RNA Lysis Reagent (5Prime). Tissues were then homoge-
nized in Mixer Mill MM301 homogenizer (Retsch) using stainless beads at 20HZ and homoge-
nates were subjected to phase separation by adding 0.2ml chloroform. The aqueous phase was
passed through gDNA column followed by RNA isolation using RNeasy Plus mini kit (Qiagen)
following the manufacturer’s protocol. The obtained RNA concentration was determined by
spectrophotometry using Nanodrop ND1000 (Thermo Scientific).
Following RNA isolation, 1μg RNA was used for cDNA synthesis using Transcription First
Strand cDNA Synthesis Kit (Roche) using both oligo (dT) and random hexamer primers, fol-
lowing the manufacturer’s protocol. The experiments/procedures reported herein have been
conducted in accordance with the laws and regulations controlling experiments/procedures in
live animals in Norway, i.e. the Animal Welfare Act of December 20th 1974, No 73, chapter VI
sections 20–22 and the Regulation on Animal Experimentation of January 15th 1996. In addi-
tion, Norway has signed and ratified The European Convention for the protection of Verte-
brate Animals used for Experimental and other Scientific Purposes of March 18th 1986. The
Norwegian legislation conforms in all respects with the basic requirements of this Convention
and guidelines prepared in pursuance of it. The National Animal Research Authority (NARA)
authority and the Norwegian University of Life Sciences´ IACUC committee have approved
the entire study.
Amplification, cloning and sequencing of the full-length EP4 receptors in
different tissues
To amplify the full-length (FL) EP4 from Atlantic salmon tissue, cDNA was diluted 1:5, 4μl of
each was used for PCR amplification (40 cycles) using Accustart Taq DNA Polymerase HiFi
(Quanta Bioscience, Gaitherburg, MD, USA) and 5pmol FL-EP4a forward and reverse primers
(Table 1). The cycling conditions were as follow: 94°C for 30sec, 60°C for 1min, 68°C for
2,5min.
PCR products were cloned into pCR2.1 vector following the protocol provided with the
TOPO TA cloning Kit (Invitrogen). The cloning reaction was transformed into E. coli Top 10
chemically competent cells (Invitrogen) and plated on LB agar medium containing 100 μg/ml
Ampicillin. The positive clones were verified by PCR, using VWR Taq DNA Polymerase
(VWR) and M13 primers (Table 1), and 10 colonies from each tissue were subsequently sent to
GATC biotech for sequencing.
Identification of a new isoform of EP4 gene in TO cells
Total RNAs were isolated from TO cells and cDNAs were synthesized as described above. Par-
tial sequences of EP4 from TO cells were obtained by PCR using randomly designed primers
(data not shown) based on the published Atlantic salmon EP4 sequence (NM_001173955.1).
Finally, the nearly full length sequence except 5’ and 3’ end was obtained by amplifying three
fragments using TO-EP4 primers (Table 1) and the PCR products were subsequently purified
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and sequenced by GATC biotech (Germany). To obtain the sequences for the 5’ and 3’ ends,
5’RACE-GSP (GTATCTCTCTAT GGACATGGCACAG) and 3’RACE-GSP (ATATACCAG
CACACACATCAGTAATGA AC) primers were designed based on the sequence information
obtained from PCR products and RACE PCR was performed using SMARTer RACE cDNA
amplification kit (Clontech) according to the manufacturer’s instructions.
Molecular phylogenetic analysis
The sequences of EP4 receptors from a number of species were obtained from GenBank: Hu-
mans (NM_000958), rat (NM_ 032076), zebrafish EP4a (NM_001039629.1), zebrafish EP4b
(NM_001128367), zebrafish EP4c (NM_001281996), mouse (NM_001136079), dog
(NM_00100 3054), chicken (NM_001081503), and cattle (NM_174589). The newly identified
EP receptor for Atlantic salmon was included in the analysis. A phylogenetic tree was con-
structed with amino acid sequences of all species above using PhyML program (http://www.
phylogeny.fr/).
Isolation of headkidney macrophages
Macrophages were isolated from the headkidney using Percoll gradient as previously described
[25]. Briefly, the tissue was passed through 100μm nylon mesh and collected in isolation medi-
um (L-15-glutamax medium containing heparin and 2% FBS). The cell suspension was then
layered on top of 37/54% Percoll gradient and centrifuged at 600g for 40 min at 4°C. The band
of cells between the two Percoll layers were collected and washed once in L-15-glutamax medi-
um containing 0.1 FBS and 100U/ml penicillin/streptomycin (Gibco). About 8x105 cells/well
were seeded in 6 wells plate and incubated overnight at 15°C in L15-glutamax medium con-
taining 100U/ml penicillin/streptomycin and 20% FBS before being subjected to RNA extrac-
tion and cDNA synthesis as described above.
Effect of PGE2 on LPS induced responses
TO cells were first starved in L-15 media (Invitrogen) containing 0.5%FBS for 12–15 hours and
then incubated for one hour with different concentrations of PGE2 (Sigma Aldrich) prepared
Table 1. List of primers used for PCR and cloning.
Name Sequence Used for Accession no
O-EP4-F1-For
TO-EP4-F1-Rev
5´-ACAAAAACACTTCGGATAGTCAAAAACC-3´ 5
´-GTATCTCTCTATGGACATGGCACAG-3´
PCR -
TO-EP4-F2-For
TO-EP4-F2-Rev
5´-CACCATCGCCACCTATGTGC-3´ 5´-GCAGATGAGAACAACCACGG-3´ PCR -
TO-EP4-F3-For
TO-EP4-F3-Rev
5´-CAACGATTGGCCGGTGCAG-3´ 5´-CTGTGACTTTTCTGTGTTATCC-3´ PCR -
FL-EP4-For FL-EP4-Rev 5´-ACAAAAACACTTCGGATAGTCAAAAACC-3´ 5
´-GGGACAAAGTTCACATTGTAGCC-3´
PCR NM_001173955.1
As-EP4a-For As-EP4a-Rev 5´- GTCAACCCCATCCTTGACCC-3´ 5´- CAGCCCCCCTTTAGTCCCCT-3´ PCR -
As-EP4b-For As-EP4b-Rev 5´-CACTGCGGAGGTGAAGGTC-3´ 5´-GGGGCCTAAAGTGCCCTTTTTG-3´ PCR -
M13-For M13-Rev 5´-GTAAAACGACGGCCAG-3´ 5´-CAGGAAACAGCTATGAC-3´ Cloning/
sequencing
-
CXCL10-For CXCL10-Rev 5´-CAGGTGGGTCATTCTAAAGC-3´ 5´-CTTGGCAAATGGAGCTTCTG-3´ Realtime PCR AJ417078.1
CCL4-For CCL4-Rev 5´-TGATCGTCAGATACCCAGAG-3´ 5´-GTTGATGTAGTCCTTCACCC-3´ Realtime PCR NM_001123618.1
IL8-For IL8-Rev 5´-GCAGACGAATTGGTAGACTC-3´ 5´-TCTTCTTAATGACCCTCTTGAC-3´ Realtime PCR NM_001140710.2
IL6-For IL6R-ev 5´-GGAGGAGTTTCAGAAGCCCG-3´ 5´-TGGTGGTGGAGCAAAGAGTCT-3´ Realtime PCR NM_001124657
doi:10.1371/journal.pone.0120483.t001
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in L-15 media supplemented with 10% FBS and 50 μg/ml gentamycin. When EP4 antagonist
L161,982 (Santa Cruz Biotech) was used 5μMwas added to the cells 45min before the incuba-
tion with PGE2. Cells were subsequently stimulated with 50μg LPS (sigma) and harvested at
different times post stimulation. Total RNA was then isolated followed by cDNA synthesis as
already described above except that 400ng total RNA was used for cDNA synthesis. Changes in
gene expression were assessed by real time PCR performed in 96 well plates using LightCycler
480 (Roche). For each reaction, 4μl cDNA was mixed with 10pmol gene specific primers and
10μl LightCycler 480 SYBR green I master mix (Roche). The final concentration was adjusted
to 20μl using RNase free water. The genes assessed and the sequences of primers used in the re-
actions are provided in Table 1. The cycling conditions were as follows: denaturation 94°C for
10 sec; Annealing 60°C for 20 sec; elongation 72°C for 10 sec. The results were analyzed by the
ΔΔCT relative quantification approach [26] using β-actin as reference gene.
cAMP assay
TO, RTG-2 and CHSE-214 cells were seeded in 6 wells plate (Corning) and incubated at 20°C
until confluency. At the time of experiment, cells were treated with 10μM PGE2 (Sigma Al-
drich), 100μM forskolin (Sigma Aldrich), or left untreated. Cells were then incubated at 20°C
for 1 hour. Prior to the assay, cells were washed three times in cold PBS and subsequently lysed
in Cell Lysis Buffer provided in the kit. The amount of cAMP was measured using the cAMP
parameter assay kit (R&D systems). The procedure was performed following the manufactur-
er’s instructions. As this assay is based on competitive binding technique, the readout value of
OD450 is inversely proportional to the concentration of cAMP.
Software. Nucleotides and amino acid sequences of EP4 were aligned by CLCWorkbench.
Phylogenetic tree was also created by the same software. One-way ANOVA followed by
Tukey´s multiple comparisons test was performed using GraphPad Prism version 6.00,
GraphPad Software, La Jolla California USA.
Results
Sequence analysis in different tissues
Sequence analysis revealed very high similarity between the published EP4 sequence (GenBank:
NM_001173955.1) and the sequences obtained from different tissues. However, a 3 nucleotide
(nt) deletion was found in the 5’ untranslated region (UTR) at nt 228–230 in all tissues except
the skin. Presence of the 3nt deletion was accompanied by silent mutation at nt 668. Addition-
ally, some of the clones from the muscle had mutation at nt 448 from thymine to cytosine re-
sulting in a Leu61Pro mutation. This mutation was only detected when the 5’UTR deletion
was abscent.
Two isoforms of EP4 are found in Atlantic salmon
While the full length EP4 sequence was easily obtained from several tissues, it could not be am-
plified from TO cells. We obtained the first half of EP4 when reverse primers were designed in
the middle of the published EP4 sequence (data not shown). For the second part of the se-
quence, we designed several primers using published Atlantic salmon EP4 sequence and based
on the fragmented sequences obtained, three PCR fragments constituting most of the sequence
of EP4 gene in TO cells were amplified (excluding the 5’ and 3’ end sequences). The sequence
for the 5’ and 3’ ends were then attained by 5’ and 3’ RACE as described in materials and meth-
ods. The result of full sequencing of EP4 gene in TO cells revealed a different isoform of EP4
(Fig. 1). We therefore designated the first published variant as As-EP4a while the second
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identified sequence in TO cells was named as As-EP4b. The length of the As-EP4b was found
to be 2346 nucleotides compared to 2423 nucleotides for As-EP4a. While the first half of As-
EP4b sequence was found to be identical to As-EP4a, many single nucleotide mutations and
segmental deletions were found from nt 1027, which is located almost half through the EP4
gene, and onwards (Fig. 1). The coding region was located from nt 267 to nt 1694 and, although
the length of nucleotide for both isoforms were different at C-terminal tail, the encoded length
of amino acids were found to be identical, 473 amino acid for both isoforms (Fig. 2). Three
amino acids were deleted at positions 389–401 in As-EP4b, whereas another three amino acid
deletion was found at position 429–431 As-EP4a. Amino acid sequences for both isoforms
were also aligned to EP4 amino acid sequences from several species (Fig. 3). Putative trans-
membrane domains (TM) 1–7 were noted based on a previous study [10]. Alignment result
showed that EP4 genes from Atlantic salmon are in general conserved compared to other spe-
cies at their seven transmembrane domains while differences in N- and C-terminals were re-
markable (Fig. 3). High homology was found between intracellular domain 1 and 2 while in
intracellular 3, a deletion of 20–30 amino acids was found only in non-mammalian species
(fish and chicken).
The sequence identities between the aligned EP receptors were summarized in Table 2. The
transmembrane (TM) domains among all the species are highly conserved. The sequence iden-
tity between the two As-EP4 sequences was 91% and they differed mainly in the TM6, third ex-
tracellular loop and C-terminal tail. Both sequences share about 71 and 64% to zebrafish EP4a
and b respectively, with the highest divergence being in the N-termini, third extracellular loop
and C-terminal tail. Notably, high sequence divergence was observed in the third intracellular
domain between mammalian and non-mammalian sequences.
Phylogenetic relationship of EP4 gene among different species
To identify the relationship of EP4 receptor sequences from Atlantic salmon and other species,
a phylogenetic tree was established using the method as described [27] (Fig. 4). Zebrafish (Zf)
EP4c appeared to be the most divergent receptor, distant from all other EP4 receptors. Apart
from this, the fish EP4 receptor formed a distinct cluster while the mammalian and chicken
EP4s with high bootstrap values formed another cluster. Within the fish cluster, the two As-
EP4 isoforms were found to be closer to Zf-EP4b receptor than Zf-EP4a.
As-EP4a and As-EP4b are differentially distributed in different tissues
and TO cells
At this point we were not sure whether As-EP4b is an isoform that is naturally present in At-
lantic salmon or it is generated during the development of TO cell line. Primers specific for As-
EP4a and As-EP4b (Table 1) were therefore designed for PCR, and the expression of the two
isoforms in several Atlantic salmon tissues and TO cells was assessed (Fig. 5). All the positive
bands seen on the electrophoresis gel were excised and sequenced. The sequence result con-
firmed that AS-EP4a and AS-EP4b are both present in Atlantic salmon tissues and differential-
ly distributed in the examined tissues (Fig. 5). In general, the mRNA of both isoforms were
more abundant in the spleen, gill, intestine, head kidney and kidney while less in liver, heart
and skin. EP4a expression was not detectable in the brain while EP4b expression was found to
be very low in muscles and liver. Both receptors were expressed in the headkidney macro-
phages but only AS-EP4b was detected in TO cells (Fig. 5).
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Fig 1. Nucleotide sequences of two EP4 subtypes. Comparison of nucleotide sequence of two subtypes
of EP4 gene identified in Atlantic salmon.
doi:10.1371/journal.pone.0120483.g001
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PGE2 modulates LPS induced inflammatory responses in TO cells
To study whether PGE2 can modulate immune response in TO cells, TO cells were treated
with LPS or pretreated with 1 or 10 μM PGE2) for 1h and subsequently stimulated with LPS.
The cells were then incubated for 2, 6, and 12h and sampled for analysis. Stimulation of TO
cells with LPS alone resulted in up-regulation of all the examined inflammatory genes (Fig. 6
A-F; control). The up-regulation was most significant at 6 hours post stimulation for all genes,
except IL-6. PGE2 pre-incubation lowered the induction of CXCL-10 (Fig. 6A), CCL-4
(Fig. 6B), IL-8 (Fig. 6C) and IL-1β (Fig. 6D) gene expression but had no clear effect on TNF-α
(Fig. 6 E). For IL-6 the expression level was lower at 2h but increased beyond control at 12h,
seemingly delaying the response at early time while inducing a second wave at later time
(Fig. 6F). The induced inhibition was found to be time dependent, with the most pronounced
effect being seen at 6 hours post stimulation. Interestingly, CCL-4 (Fig. 6B) was significantly
down-regulated by PGE2 at all the examined time points.
Treatment with EP4 antagonist has no effect of PGE2 induced
immunomodulation
To examine whether the immunomodulatory effect induced by PGE2 is mediated through EP4
receptors, TO cells were also pre-treated with EP4 antagonist prior to stimulation with PGE2.
No significant differences were observed between antagonist treated and untreated cells (Fig. 7)
indicating that EP4 antagonist L161,982 had no effect on the PGE2 induced inhibition of
immune responses.
PGE2 induced immunomodulation in TO cells does not involve cAMP
up-regulation
To investigate the involvement of cAMP signaling pathway in PGE2 induced effect, the in-
crease of cAMP concentration upon PGE2 treatment was assayed. In TO cells, no significant
increase was detected. We included two additional fish-derived cell lines (CHSE-214 and RTG-
2 cells, both from salmonid species) and both showed strong cAMP increase in response to
PGE2 treatment (Fig. 8). We then included forskolin treatment as a positive control (including
all said cells) and found that forskolin results in up-regulation of cAMP in CHSE-214 and
RTG-2 while TO cells cAMP levels remained unchanged post stimulation (Fig. 9).
Fig 2. Amino acid sequence of two EP4 variants in salmon.Comparison of amino acid sequence of two subtypes of EP4 gene identified in
Atlantic salmon.
doi:10.1371/journal.pone.0120483.g002
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Discussion
In the present study, we report the identification of a new isoform of the EP4 receptor in Atlan-
tic salmon. The presence of redundant gene copies due to genome duplication has been ob-
served in Atlantic salmon [28]. Some of these copies can be non-functional, but the fact that
both identified sequences have the same amino acid length and strong expression in several tis-
sues opt us to propose a new functional isoform of the EP4 receptor. Presence of multiple EP4
isoforms in zebrafish [20] and the difference we found in the C-terminal tail that determines
the signaling cascade will be in support for our interpretation. Whether these isoforms are gen-
erated by alternative splicing, as for EP3 in higher vertebrates [29,30] or by gene duplication re-
mains to be determined. Further studies are needed, first to identify the functions and the
signaling cascade mediated by both isoforms; and secondly to determine whether the functions
of these different EP4 isoforms are conserved across fish species. In this regard, comparative
studies between fish and mammalian EP4 are required to understand why fish functionally
benefit from additional EP4 isoforms. The expression of the mRNA of the different EP4 iso-
forms in zebrafish was found tissue specific, suggesting that each subtype may mediate specific
function [20]. We found that both isoforms are co-expressed in several tissues in Atlantic salm-
on. This indicates that the functions of the different EP4 isoforms may not be identical across
fish species, and that in some species the receptors have evolved to be more specialized than
others. Presence of multiple isoforms in one tissue may also serve as a source for functional di-
versity as different isoforms may have different ligand binding avidity, regulating function by
direct competition or have different intrinsic properties such as G protein binding and receptor
desensitization [14,30–32].
Duplication in the genome may lead to presence of paralogs of the same genes. Paralogs
may have the same function as the ancestral gene, a sub-functionalization in a way where the
function of the ancestral gene is divided between the different paralogs or diverge to acquire
function that is not present in the ancestral gene [33,34]. Indeed, presence of paralogs has been
previously demonstrated in Atlantic salmon [35]. The sequences obtained from different tis-
sues in the current study were very homologous and similar to the previously published EP4
Fig 3. Alignment of EP4 amino acid sequence in different species.Differences in amino acids are highlighted by shading. Putative transmembrane
domains (TM) 1–7 are shown by the rectangular boxes. Intracellular domains (Intra) 1–3, extracellular (Extra) domains 1–3, N-and C-terminal domains are
noted in the beginning of the sequences.
doi:10.1371/journal.pone.0120483.g003
Table 2. Sequence identities between As-EP4a and other aligned EP4 sequences from different species.
Identities N-
terminal
TM1 Intra1 TM2 Extra1 TM3 Intra2 TM4 Extra2 TM5 Intra3 TM6 Extra3 TM7 C-
terminal
As-EP4b 100 100 100 100 100 100 100 100 100 100 100 86 81 95 80
Zf-EP4a 21 76 82 96 62 82 82 63 73 84 75 82 38 86 30
Zf-EP4b 6 90 82 100 69 86 91 79 59 80 82 73 38 95 40
Zf-EP4c 11 55 73 78 69 50 68 26 62 40 30 68 24 76 22
Chicken-
EP4
25 81 91 93 54 86 86 79 58 80 69 86 43 90 37
Mouse-EP4 26 70 91 93 46 86 86 79 65 92 46 86 33 95 41
Rat-EP4 26 70 91 93 46 86 86 74 65 92 46 86 33 95 39
Dog-EP4 26 70 91 93 62 86 86 74 65 92 43 86 38 90 40
Cattle-EP4 21 70 91 93 54 86 86 74 65 92 44 86 48 90 41
Human-EP4 32 70 91 93 54 82 86 74 65 88 48 86 38 95 39
doi:10.1371/journal.pone.0120483.t002
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sequence, designated as EP4a in this study [21]. However, based on the presence of some com-
mon mutations or deletions they can be divided in three categories: 1) Sequences that are iden-
tical to the published sequence, 2) sequences that have 3 nt deletions in the UTR, and 3)
sequences that have prolin instead of leucin at residue 61. These sequences may reflect different
paralogs especially the two first sequences since they were both found expressed in almost all
the examined tissue. Due to the high sequence homology we consider it unlikely that these se-
quences will have different functions. However, presence of deletion in the regulatory 5’-UTR
region, which is important for translation regulation [36], in one of the sequences suggest that
a difference in protein expression levels may occur.
The immunomodulatory effect of PGE2 on LPS induced inflammation has been extensively
studied in higher vertebrates. In human macrophages, PGE2 was shown to suppress LPS in-
duced mRNA and protein expression of CCL-4, IL-8 [37]. Similarly we found that PGE2 pre-
treatment lowered LPS induction of both genes and in addition IL-β and CXCL-10 mRNA
expression were lowered in TO cells (salmon macrophage cell line). Although the LPS and
PGE2 dose used varied between the two studies, the timing when significant inhibition was de-
tected was similar (7 hours for human macrophages and 6 hours for TO cells). These findings
are suggestive of PGE2 being an immunomodulator also in salmonid fish, indicating the func-
tion is conserved. While PGE2 was also found to impact on IL-6 and TNFα gene expression in
mouse peritoneal macrophages during inflammatory response [38], we found no clear effect
Fig 4. Phylogenetic tree of EP4 receptors from different species. The sequence of Atlantic salmon (As)
and zebrafish (Zf) are compared.
doi:10.1371/journal.pone.0120483.g004
Fig 5. Distribution of EP4a and EP4b in different tissues of salmon. As_EP4a and As_EP4b gene distribution in different tissues are shown. Key: H:
Heart. S: Spleen.G: Gill. HK: Head Kidney.B: Brain, I: Intestine,K: Kidney,M: Muscle, L: Liver, Sk: Skin, TO: TO cell line,MØ: Headkidney Macrophages. β-
actin gene was used as internal control.
doi:10.1371/journal.pone.0120483.g005
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for PGE2 on the induction of these genes. This difference might be explained by the different
inflammatory model used but could also be due to dose effect specially for TNFα since both in-
hibition and suppression of production can be induced by using different doses of PGE2 [39].
The diverse roles that PGE2 plays in inflammatory response can largely be attributed to the
multiple receptors and signaling cascades that can be activated [40,41]. Both EP2 and EP4 were
shown to mediate the anti-inflammatory effect induced by PGE2 on LPS-induced inflamma-
tion in murine and human macrophages, respectively [37,42]. In the present study we have in-
vestigated the role of AS-EP4 receptors in mediating the anti-inflammatory effect of PGE2.
While the two characterized EP4 isoforms were present in headkidney macrophages, only
EP4b was detected in TO cells. Thus, TO cells can be used as a knock out model to study the
differential roles of EP4a and EP4b in mediating PGE2 induced effects. We could not reverse
Fig 6. Modulation of responses of defined genes after PGE2 treatment and LPS stimulation in TO cells. Immune response to PGE2 stimulation in TO
cells. A) CXCL-10; B) CCL4; C) IL8; D) IL-1β and F) IL6. Different timepoints post LPS stimulation is are indicated. * = p<0.05; ** = p<0.001. Average ± SEM is
shown (n = 3).
doi:10.1371/journal.pone.0120483.g006
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the anti-inflammatory effect induced by PGE2 on LPS induced inflammation by using EP4 an-
tagonist for mammals. There are two possible explanations for this finding; either the effect is
not mediated by EP4b or the antagonists does not bind effectively to the AS-EP4b.
The lack of cAMP induction in TO cells after PGE2 stimulation may also be explained by
involvement of other variants of PGE2 receptors. The EP4 receptor was initially thought to be
coupled only to Gsα, and therefore induce responses that are mediated only through cAMP
Fig 7. Effect of EP4 antagonist. No significant differences were observed between antagonist
L161,982-treated and untreated cells.
doi:10.1371/journal.pone.0120483.g007
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signaling, while recent studies have shown that it can also be coupled to Giα, which inhibit
cAMP production [43]. Further, the involvement of other signaling pathways for EP4 mediated
responses has been demonstrated. For example, The EP4 agonist ONO-AE1-329 was shown to
attenuate the chemotaxis of human peripheral blood eosinophils independent of cAMP
through the phosphatidyl-inositol 3-kinase (PI3K) pathway [44]. The possibility of the anti-in-
flammatory effect induced by PGE2 in TO cells being mediated through EP4 receptor via
cAMP independent pathway, such as PI3K, cannot be ruled out and should be further investi-
gated. Another factor that can explain the lack of cAMP involvement and that would require
further investigation is the type of the cAMP generating enzyme adenylyl cyclase (AC)
Fig 8. cAMP induction post PGE2 treatment. Three cell lines, CHSE-214, RTG-2 and TO were used in this
experiment. Cells were either treated with PGE2 (P) or left without treatment (C).
doi:10.1371/journal.pone.0120483.g008
Fig 9. cAMP induction post forskolin treatment. Three cell lines, CHSE-214, RTG-2 and TO were used in
this experiment. Cells were either treated with forskolin or left untreated (controls). * = p<0.01 between
control and the two treatments. Average ± SEM is shown (n = 3).
doi:10.1371/journal.pone.0120483.g009
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expressed. Some of these ACs are Gs sensitive while others are Gi sensitive [45] and the absence
of Gs-sensitive isoforms may also lead to lack of cAMP stimulation.
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